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Introduction. Chronic rhinosinusitis is a highly prevalent disease, so it is necessary to create valid instruments to assess the quality
of life of these patients. The SNOT-20 questionnaire was developed for this purpose as a specific test to evaluate the quality
of life related to chronic rhinosinusitis. It was validated in the English language, and it has been used in most studies on this
subject. Currently, there is no validated instrument for assessing this disease in Portuguese. Objective. Cross-cultural adaptation
and validation of SNOT-20 in Portuguese. Patients and Methods. The SNOT-20 questionnaire underwent a meticulous process
of cross-cultural adaptation and was evaluated by assessing its sensitivity, reliability, and validity. Results. The process resulted in
an intelligible version of the questionnaire, the SNOT-20p. Internal consistency (Cronbach’s alpha = 0.91, P < .001), reliability
testing-retesting (r = 0.994, P < .001), content validity, validity of discrimination of patients without chronic rhinosinusitis
(U = 44, P < .0001) and assessment of sensitivity to change (SRM = 1.53 and 1.09) were evaluated. Conclusion. We conducted a
successful process of cross-cultural adaptation and validation of the SNOT-20 questionnaire into Portuguese.

1. Introduction
Rhinosinusitis (RS) is one of the most common complaints
presented in physician oﬃce visits. About 31 million people
are aﬀected in the United States (USA) each year, with
an annual cost of six billion dollars. It is one of the
main reasons for prescribing antibiotics and lost worker
productivity [1–3]. RS that lasts more than 12 weeks is
called chronic rhionosinusitis. The Chronic rhinosinusitis is
divided into with and without nasal polyps, distinguished by
clinical examination, histopathology, and prognosis profile
of interleukin [4]. The chronic RS is also a common reason
for surgery, with more than 200,000 sinusectomies held each
year in the USA [5].
Specific instruments to measure quality of life related
to RS have been developed by the need to better assess the
morbidity of a disease and the evolution and impact of treat-

ments. Measures of quality of life related to RS with validity
and reliability are crucial for assessing treatment outcomes
of CRS [6]. In the past, some studies demonstrating the
benefits of antibiotics presented as the primary endpoint
only the descriptive report of improvement of symptoms of
the patient, for example. Quality of life is seen in a diﬀerent
state of health. It is the only personal experience that reflects
not only the health, but also other factors and circumstances
in the patient’s life that only he can express [7].
The incorporation of a validated and standardized
instrument for assessing quality of life in a study is very
important because it allows comparison of results with other
studies, depending on the instrument with other diseases
[7]. The study entitled “Medical Outcomes Study ShortForm 36-Item Health Survey (SF-36)” shows any increased
morbidity, in measures of bodily pain and social function in
patients with RS more than for patients with congestive heart
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failure, angina, chronic obstructive pulmonary disease, or
back pain, suggesting a far greater impact than was currently
assessed for the RS [8].
A health-related and disease-specific instrument for
quality of life evaluation called “20-Item Sino-Nasal Outcome Test” was created and validated for use in the English
language, and its use is widespread in the literature by the
countries of this language [6]. Known as SNOT-20 (Annex I),
it has been validated for use in German [9]. The adaptation
and validation in our language is not only essential for its
proper use but also allows the comparison of our results with
published results in all other languages in which the same
questionnaire was validated.
No version of this questionnaire of quality of life has yet
been validated for use in Portuguese. A Portuguese version
would give us better opportunities for evaluation of patients
in studies and more accurate comparison of results with
other treatments.

2. Objective
Validation and cross-cultural adaptation of the SNOT-20
(Sino-Nasal Outcome Test) in Portuguese is the objective of
this paper.

3. Methods
3.1. Patients. This is a prospective cohort study conducted at
Clinics Hospital, University of São Paulo after Ethics Committee approval. All patients agreed and signed informed
consent.
(I) Inclusion criteria
(a) Patients with CRS, defined as the presence, for a
period exceeding twelve weeks, of two or more of
the following four symptoms, and one of these
should be the first two: nasal blockage, obstruction
or congestion, nasal discharge (anterior or posterior
nasal drip), facial pain or pressure, and reduction or
loss of smell [3];
(b) age of at least 18 years;
(c) good general health with no systemic or localized
diseases that compromise or may compromise it.
(II) Exclusion Criteria
(a) Patients with secondary causes of RSC: fungal ball,
invasive fungal disease, granulomatous diseases, vasculitis, isolated mucoceles, benign and malignant
sinonasal tumors, congenital abnormalities (such as
primary ciliary dyskinesia and cystic fibrosis), and
oro-antral fistula;
(b) pregnancy and lactation;
(c) congenital craniofacial abnormalities;
(d) primary or secondary immunodeficiencies.

3.2. Translation and Cross-Cultural Adaptation. We conducted the process of translation and cross-cultural adaptation from the original version of SNOT-20 instrument in
English, following standardized rules for this purpose [10].
(1) Two bilingual translators whose native language was
Portuguese produced two separate versions of the
instrument in this language: version T1 (translator
with medical knowledge) and version T2 (translator
without medical knowledge).
(2) The two versions were synthesized into a final
version in Portuguese (SNOT-20p version) through
a meeting with the two translators and one outside
observer with ENT background.
(3) The SNOT-20p was backtranslated into English (BT
version) by two bilingual translators with English
as their native language (BT1 and BT2 versions)
independently. The new version in English version
(BT) was synthesized from a meeting with the
two translators and one outside observer with ENT
background.
(4) The six versions were sent to the author of the
original English version, so that he could certify
that the original meaning of the questionnaire had
been maintained and to authorize the start of the
validation process in Portuguese.
3.3. Validation. Patients with chronic rhinosinusitis who
underwent endoscopic sinus surgery responded to the questionnaire in four stages as follows: fifteen days before the
surgery, the day before surgery, six months after surgery, and
twelve months after surgery.
3.4. Statistical Analysis. Internal consistency reliability was
estimated by Cronbach’s alpha [11] and test-retest reliability of the questionnaire about fifteen days after the first
evaluation (Wilcoxon signed-rank test and Spearman’s rank
correlation coeﬃcient). Discriminant validity was estimated
by comparing total scores of the results between two diﬀerent
groups of the department of otolaryngology, patients with
CRS, and patients with appointments for other reasons and
without clinical conditions compatible with CRS (MannWhitney U-test). Sensitivity for clinical change was calculated by standardized response mean (SRM). We also
evaluated the mean SNOT-20 score and mean SNOT-20
score for five important items and variations collected after
six and twelve months (Friedman test and Wilcoxon signedrank test).
An alpha of 0.05 was considered statistically significant
for all statistical tests. Data analysis was performed using
SPSS 10.0 (SPSS Inc, Chicago, IL).

4. Results
This study was conducted in a tertiary care center from
February 2008 to October 2010. The SNOT-20 questionnaire
was answered by 38 patients with median ages of 42.5
± 18.2 (20–76) years (median (md) ± interquartile range
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(IQR)), of which 63% were men. All patients completed the
questionnaire before surgery, but only 32 responded after
6 months, and only 34 after 12 months of surgery. The
SNOT-20 scores preoperatively and after 6 and 12 months
of surgery were 1.75 (±2.04), 0.68 (±1.07), and 0.90 (±1.64)
(md (±IQR)), Friedman Test, P < .0001. The items most
commonly chosen as the worst in the preoperative and
the percentage selected were “Need to blow nose” (57.9%),
“Sneezing” and “Postnasal discharge” (42.1%), and “Thick
nasal discharge,” “Diﬃculty falling asleep,” and “Wake up
tired” (31.6%).
The Cronbach’s alpha was 0.91 (P < .001). Reliability
was evaluated by test-retest and demonstrated by the high
Spearman correlation coeﬃcient (r = 0.994, P < .001). The
average diﬀerence in SNOT-20 scores in evaluating the reliability of the testing-retesting was not statistically significant
(Mean ranks (reproduction versus day before surgery) 6.92.
versus 4.90, P = .448, Wilcoxon signed-rank test).
The content validity of the questionnaire was ensured by
how the original version was developed, and by literature
review, by interviews with patients and discussion with
experienced otolaryngologists. This thorough process aimed
to help the maintenance of the practical purpose of this
instrument. The instrument was sent to the author in English
to prove that the original meaning had been maintained.
Twenty-five patients of the Otorhinolaryngology Department without sinonasal complaints responded to the questionnaire SNOT-20p. The median score of patients without
sinonasal complaints was 0.39 ± 0.49 and suggested few
complaints on the questionnaire. The validity of discrimination between patients with and without chronic sinusitis was
confirmed by Mann-Whitney t-test that showed a statistically
significant diﬀerence between groups (U = 44, P < .001).
The SRM was 1.53 and 1.09, six and twelve months
after surgery, respectively. These results suggested a high
sensitivity to change for both measures.
The Wilcoxon signed-rank test showed that the diﬀerence
between the median SNOT-20p on 5 items selected as most
important for each patient and the median overall score was
higher and statistically significant in the initial visit (3.97
± 1.03 (md ± IQR) versus 2.16 ± 1.17, (P < .001), after
6 months (1 . 33 ± 1.12 (md ± IQR) versus 0.89 ± 0.80,
(P < .001)), and after 1 year (1.53 ± 1.36 (md ± IQR)
versus 1.16 ± 1.01, (P < .002)). The change in SNOT-20
questionnaire for the important items was also statistically
higher than the average overall score after 6 months (−2.76
± 1.07 (md ± IQR) versus −1.40 ± 0.84, (P < .001)) and
after 1 year (−2.46 ± 1.37 (md ± IQR) versus −1.05 ± 0.87,
P < .001)). The SRM for these most important items was
higher after six months (2.42) and 1 year after surgery (1.74).

5. Discussion
This paper concludes the process of cross-cultural adaptation
and validation of disease-specific QOL questionnaire SNOT20 for Portuguese-speaking physicians to evaluate patients
with CRS. The process of translation and cross-cultural
adaptation was completed without any diﬃculty and resulted

3
in a questionnaire version in Portuguese, the SNOT-20p,
with the contents maintained. The process ensures that any
study that uses the Portuguese questionnaire SNOT-20p and
makes reference to this paper of validation can publish and
compare the results with the SNOT-20 questionnaire used
in any other study in English or another language that has
validated the questionnaire.
Internal consistency (Cronbach’s alpha = 0.91, P < .001),
reliability of test-retest (r = 0.994, p < .001), content
validity, validity of discrimination with patients without
chronic rhinosinusitis (U = 44, P < .001), and assessment
of sensitivity to change (SRM = 1.53 and 1.09) were tested
during the validation process. It was also shown how the
five items chosen by the patient as most important are more
sensitive in detecting changes in this instrument than the
value of the overall score (SRM = 2.42 and 1.74).
The instruments that assess the disease-specific quality of
life for some disorders are necessary because sometimes the
changes caused by them can be small or specific to certain
disease that instruments to assess the global health or specific
symptoms could not identify [12].
There are many other instruments available and validated
to assess the impact of rhinosinusitis on quality of life,
its evaluation and impact in the treatment. The RSOM31 (from the English “Rhinosinusitis outcome measure”)
contains 31 questions divided into seven areas; however
the scale at which the patients were required to answer,
was a little diﬃcult to interpret [13]. The RSDI (from the
English “Rhinosinusitis Disability Index”) relates sinonasal
symptoms to specific limitations in daily life also through
30 questions, similar to RSOM [14]. The RQLQ (from the
English “Rhinoconjunctivitis Quality of Life Questionnaire”)
is a questionnaire for allergic symptoms and is not validated
for sinusitis [15].
The SNOT-20 is a modified version of RSOM-31 in
which eleven items were removed either by their redundancy,
or because they do not contribute significantly to the instrument. Furthermore, the fashion of the score of responses and
the composition of the result of the questionnaire has been
simplified, and the five items considered most important
compose another score to analyze the results in complaints
more uncomfortable for the patient [7].
All these instruments were validated and applied in
prospective studies in rhinosinusitis. The SNOT-20 is chosen
as an outcome measure in most studies published on rhinosinusitis. We chose to validate the SNOT-20 because it is an
instrument that assesses several important dimensions and
specific quality of life of patients with chronic rhinosinusitis.
Most patients in our pilot study responded quickly and easily
to it. This instrument will allow us to generalize the results of
national studies and compare them with other international
studies.
The SNOT-22 is a recently validated instrument [16]
formed by the simple addition of the evaluation of smell
and nasal obstruction in SNOT-20. It is an important tool
that has its role, but we believe that in most prospective
studies it would be more precise to evaluate smell by specific
tests, like the UPSIT [3]. Likewise, it is more specific to
assess diﬀerent aspects of nasal obstruction with the NOSE
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questionnaire [12]. Let us consider the other sides of the
nasal obstruction because the patient often does not bother
with these complaints but complains of nasal congestion or
diﬃculty of breathing through his or her nose.
We chose to use these simple and rapid application tools
in our studies because they evaluate these complaints in
a meticulous fashion. We used a validated version of the
NOSE questionnaire in Portuguese which has already been
accepted for publication (the English “Nasal Obstruction
Symptom Evaluation”) (Bezerra et al.) to assess the specific
quality of life related to nasal obstruction. It could be used
to evaluate any nasal disease related to that complaint, not
only chronic rhinosinusitis. The UPSIT allows a broader
assessment of hyposmia than a single question to the
patient. The completion of the validation of the UPSIT test
(University of Pennsylvania Smell Identification Test) for the
Portuguese by Fornazieri et al. will allow an objective and
specific assessment of the sense of smell in our Brazilian
patients. The instrument already in use in Brazil contained
some cultural diﬀerences, and the adaptation process will
seek to produce a version closer to our culture.
The reliability of an instrument could be assessed by
its internal consistency and the maintenance of the score
over time when the patient’s condition does not change. The
internal consistency of the SNOT-20 assesses how each item
relates to the instrument against the other items and against
the final score. The Cronbach’s alpha of 0.91 demonstrates
a high internal consistency and a level necessary for clinical
application (>0.9). The test-retest reliability is achieved when
we apply the instruments at diﬀerent times and analyze the
correlation between the scores, which was also demonstrated
by the questionnaire (r = 0.994, P < .001) [7].
The content validity of the questionnaire was ensured
by the methodology used in developing the questionnaire as
described above. There were four independent translations
and two synthetic ones in a process of translation and
retranslation. We emphasize that methodology allowed an
adaptation process of the local version of the questionnaire
according to international standards and maintaining the
original meaning [10]. The participation of the author of the
original questionnaire at this stage ensured the maintenance
of the meaning of the instrument. The process could have
generated a simple translation tool that was not equivalent
to the original questionnaire and in capable of comparing
responses across populations and generalization of data.
The importance of the patient choosing five items considered most important could be shown by more significant
results detected in these items than on the overall score.
The assessment of these five items, about which patients
care most, demonstrated how these items have changed. The
data also showed that the evaluation of outcome in these
five items is much more sensitive to change than the overall
questionnaire.
The validation of the SNOT-20 questionnaire for the
Portuguese language opens up new frontiers for the generalization of data from our research, so now we can compare
results with research from other countries in a much more
accurate way. It is demonstrated to be a valid instrument for
assessing what it intended to assess and to be highly sensitive
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to changes because the score of the instrument changes
when the patient’s condition also changes. It also showed a
significant discrimination between patients with and without
chronic rhinosinusitis. It is a valuable tool, and together
with the NOSE questionnaire and UPSIT test, it allows the
complete evaluation of nasal or sinonasal complaints in our
patients. It could be used to compare disease-specific quality
of life before and after treatments, between diﬀerent groups
of patients, to compare diﬀerent treatments and to compare
surgical techniques.
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